VT4-33663-90621 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-24
Dose 1 — Moderna
2022-06-26
Registered in v-safe
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-28
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site

Free text: Mysterious mild rash around collarbone area developed the following day after injection. Lasted for about 24hrs, now gone

MedDRA releases: 2024-11 · check-in free text available
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-01
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-08
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-17
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-25
Survey response — 3 months, dose 1, under 3
MedDRA: Nasopharyngitis, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Back to back URI / cold viruses. Both times tested for Covid, both times negative.

MedDRA releases: 2024-11 · check-in free text available
2022-09-25
Report sent to call center — 3 months, dose 1, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-26
Call 1 — Left Voicemail
2022-12-23
Survey response — 6 months, dose 1, under 3
MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Influenza A. 10 days

MedDRA releases: 2024-11 · check-in free text available
2022-12-23
Report sent to call center — 6 months, dose 1, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-27
Call 2 — Left Voicemail
2022-12-27
Call 1 — Left Voicemail
2023-06-24
Health check-in — 12 months, dose 1, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-24	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-09-25	Unsuccessful
2022-12-23	Unsuccessful

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-28

Systemic reaction (other): Mysterious mild rash around collarbone area developed the following day after injection. Lasted for about 24hrs, now gone

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-09-25

Symptoms: Back to back URI / cold viruses. Both times tested for Covid, both times negative.

Release 12 (Under 3) — 6 months, dose 1, under 3

2022-12-23

Symptoms: Influenza A. 10 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Upper respiratory tract infection	·	·	✓
SRO	Rash	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release